While the overall incidence of TP53 mutations in GIST is relatively low (3.5%), they are more commonly observed in gastric GISTs, which are associated with poorer recurrence-free survival (RFS) [10]. The gene discussed is TP53; the disease is gastrointestinal stromal tumor.